Drug intelligence / Profile preview

Floseal Hemostatic Matrix

Development stage
Unknown
Lead developer
Baxter
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Floseal Hemostatic Matrix is a topical hemostatic agent consisting of a proprietary combination of bovine-derived gelatin granules and human or recombinant thrombin. It is designed to control bleeding during surgical procedures when conventional methods like pressure, ligature, or cautery are ineffective or impractical. The gelatin granules provide a physical scaffold (tamponade effect) that conforms to irregular wound surfaces, while the thrombin component actively converts the patient's endogenous fibrinogen into a stable fibrin clot. This dual mechanism allows for rapid hemostasis, typically within two minutes. The product was extensively studied by the Hospital for Special Surgery in New York, specifically in the context of reducing blood loss and transfusion requirements during unilateral total knee arthroplasty.

Brand names
Floseal
Other names
Hemostatic MatrixFloseal Hemostatic Matrix
02

Targets

F5 (Coagulation Factor V)F8 (Coagulation Factor VIIIa)Coagulation Factor XIIIF2R (Protease-activated receptor 1)PAR4 (Protease-activated receptor 4)

Beyond the preview

Go deeper on Floseal Hemostatic Matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Floseal Hemostatic Matrix.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call